Skip to content
  • Home
  • Company
    • About Us
    • Departments
    • Message From MD
  • Product
    • General
    • Hormones
    • Urology
    • Steroids
  • Media
    • Insights
    • Blogs
    • Gallery
  • Careers
  • Contact Us
Menu
Home / Urology / Benign Prostatic Hyperplasia Agents / PROSFLO
Benign Prostatic Hyperplasia Agents

PROSFLO

Silodosin is an alpha-1 adrenergic receptor antagonist used to treat symptoms associated with benign prostatic hyperplasia (BPH).

QR Code

General Info

COMPOSITION:

Prosflo 4
Each capsule contains
Silodosin 4 mg

Prosflo 8
Each capsule contains
Silodosin 8 mg

SUMMARY:

Silodosin is an alpha-1 adrenergic receptor antagonist used to treat symptoms associated with benign prostatic hyperplasia (BPH).

DOSAGE FORM:

Capsules

PHARMACOLOGICAL CATEGORY:

Alpha-1-adrenoceptors blockers

THERAPEUTIC CATEGORY:

Benign Prostatic Hyperplasia Agents

INDICATIONS:

Benign Prostatic Hyperplasia.

DOSAGE AND METHOD OF ADMINISTRATION:

Route of Administration: Oral

The dose must be as directed by the physician. It is recommended to be taken with food.

This medication should not be sued in women and children as safety and efficacy has not been established.

CONTRAINDICATIONS :
  • Known hypersensitivity to Silodosin or any other components of the formulation.
  • Severe renal and hepatic impairment.
  • Should not be administered to patients using concomitant strong CYP3A4 inhibitors or P-glycoprotein inhibitors and other alpha-blockers.
  • Women and children
PREGNANCY AND LACTATION:

Not indicated nor recommended for use in women.

STORAGE AND HANDLING:

Keep the medication stored at normal room temperature and out of reach of children and pets. Dispose unused medications and expired medications properly to avoid adverse effects.

Related Products

PROSTAM
  • BPH symptom relief
  • AUR (Acute Urinary Retention) & BOO (Bladder Outlet Obstruction) support
  • Aids passage of small stones

Benign Prostatic Hyperplasia Agents

PROSTAM

UROXATE
  • Urinary frequency & incontinence
  • Dysuria & urinary urgency
  • Nocturia
  • Bladder spasms (post-catheter/procedures)
  • Cystitis & related urinary tract inflammation

Urinary Tract Spasmolytic

UROXATE

MILAGE
  • Erectile dysfunction (ED)
  • Benign prostatic hyperplasia (BPH)
  • Lower urinary tract symptoms (LUTS)
  • Pulmonary arterial hypertension (PAH)

Benign Prostatic Hyperplasia Agents

MILAGE

PROSTIF
  • Benign prostatic hyperplasia (BPH)
  • Symptom relief in enlarged prostate
  • Reduces risk of acute urinary retention
  • Decreases need for BPH surgery

Benign Prostatic Hyperplasia Agents

PROSTIF

OHM Insights

View Detail

OHM INSIGHT 23nd Issue

View Detail

OHM INSIGHTS- 22th Issue

View Detail

OHM INSIGHT 21st ISSUE

View Detail

OHM INSIGHTS- 20th Issue

OPL believes in developing medicines and products that are cost-effective as well are capable of providing high quality care to improve the health of the patients.

Quick Links
  • About Us
  • Contact Us
  • Products
  • Dealer Locator
  • Blogs
  • Our Team
  • Career
Product Category
  • General
  • Urology
  • Steroids
  • Hormones
Corporate Office
(+977) 4110791, 01-4110761
info@opl.com.np
Babu Ram Acharya Marg, Sinamangal, Kathmandu
Factory Office
(+977) 4110791, 01-4110761
info@opl.com.np
Tathali-09, Bhaktapur

Copyright 2026 OHM Pharmaceuticals Lab Pvt. Ltd. All Rights Reserved

Website Designed & Developed by Theme Nepal